Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2019 Aug 29;28(10):1687–1693. doi: 10.1158/1055-9965.EPI-19-0008

Figure 2.

Figure 2.

(A) Cladogram from LEfSe analyses of differentially abundant taxa comparing BE patients without dysplasia (NDBE) or LGD vs. HGD or EAC. (B) Subjects with HGD or EAC had reduced relative abundance of Veillonalla (left), and had increased proportion of samples with presence of the other differentially abundant taxa (right), which were relatively rare. (Presence defined as having any reads, except for Enterobacteriaceae, which was defined as relative abundance >0.1%.)